Clinical Trials
2 trialsNCT05647122 2026-05-11
EGRET
AstraZeneca
Phase 1 Recruiting
NCT05954871 2025-11-13
Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer
Genentech, Inc.
Phase 1 Completed